1. Home
  2. IDYA vs ATKR Comparison

IDYA vs ATKR Comparison

Compare IDYA & ATKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • ATKR
  • Stock Information
  • Founded
  • IDYA 2015
  • ATKR 1959
  • Country
  • IDYA United States
  • ATKR United States
  • Employees
  • IDYA N/A
  • ATKR N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • ATKR Industrial Machinery/Components
  • Sector
  • IDYA Health Care
  • ATKR Miscellaneous
  • Exchange
  • IDYA Nasdaq
  • ATKR Nasdaq
  • Market Cap
  • IDYA 2.6B
  • ATKR 3.0B
  • IPO Year
  • IDYA 2019
  • ATKR 2016
  • Fundamental
  • Price
  • IDYA $26.64
  • ATKR $89.04
  • Analyst Decision
  • IDYA Strong Buy
  • ATKR Buy
  • Analyst Count
  • IDYA 12
  • ATKR 5
  • Target Price
  • IDYA $53.08
  • ATKR $131.60
  • AVG Volume (30 Days)
  • IDYA 750.9K
  • ATKR 616.8K
  • Earning Date
  • IDYA 11-04-2024
  • ATKR 11-21-2024
  • Dividend Yield
  • IDYA N/A
  • ATKR 1.44%
  • EPS Growth
  • IDYA N/A
  • ATKR N/A
  • EPS
  • IDYA N/A
  • ATKR 14.24
  • Revenue
  • IDYA $3,922,000.00
  • ATKR $3,283,645,000.00
  • Revenue This Year
  • IDYA N/A
  • ATKR N/A
  • Revenue Next Year
  • IDYA $158.10
  • ATKR N/A
  • P/E Ratio
  • IDYA N/A
  • ATKR $6.25
  • Revenue Growth
  • IDYA N/A
  • ATKR N/A
  • 52 Week Low
  • IDYA $26.41
  • ATKR $80.11
  • 52 Week High
  • IDYA $47.74
  • ATKR $194.98
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 33.96
  • ATKR 47.05
  • Support Level
  • IDYA $27.52
  • ATKR $85.87
  • Resistance Level
  • IDYA $32.67
  • ATKR $105.28
  • Average True Range (ATR)
  • IDYA 1.44
  • ATKR 3.79
  • MACD
  • IDYA -0.04
  • ATKR -0.14
  • Stochastic Oscillator
  • IDYA 3.75
  • ATKR 20.27

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. It is engaged in applying capabilities across multiple classes of precision medicine, including direct targeting of oncogenic pathways and synthetic lethality. The company's product candidate IDE196 is a protein kinase C, or PKC, an inhibitor for genetically defined cancers having GNAQ or GNA11 gene mutations.

About ATKR Atkore Inc.

Atkore Inc is a diversified industrials company and a manufacturer of electrical, mechanical, and safety infrastructure solutions. Atkore has two business segments: electrical and safety and infrastructure. Net sales are highest in the electrical business line as well as in the United States. The key product categories in the electrical segment are PVC conduit, steel conduit, and PVC-coated conduit, which are staples for electrical distributors. The key product categories in the safety and infrastructure segment include in-line galvanized mechanical tube, metal framing and related fittings, and security bollards. Also, the company provides ancillary services to customers in the form of slitting and cutting structural steel sheets.

Share on Social Networks: